Rationale for targeting the immune system through checkpoint molecule blockade in the treatment of non-small-cell lung cancer

by Zielinski, C., Knapp, S., Mascaux, C., Hirsch, F.
Published 2013

Two types of human Th17 cells with pro- and anti-inflammatory properties and distinct roles in autoinflammation

by Noster, R, de Koning, H, Sallusto, F, Zielinski, C
Published 2015

Paclitaxel and carboplatin in patients with metastatic urothelial cancer: results of a phase II trial.

by Zielinski, C. C., Schnack, B., Grbovic, M., Brodowicz, T., Wiltschke, C., Steger, G., Pflüger, H., Marberger, M.
Published 1998

Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study.

by Wiltschke, C., Krainer, M., Budinsky, A. C., Berger, A., Müller, C., Zeillinger, R., Speiser, P., Kubista, E., Eibl, M., Zielinski, C. C.
Published 1995

Brain-only metastatic breast cancer is a distinct clinical entity characterised by favourable median overall survival time and a high rate of long-term survivors

by Berghoff, A S, Bago-Horvath, Z, Ilhan-Mutlu, A, Magerle, M, Dieckmann, K, Marosi, C, Birner, P, Widhalm, G, Steger, G G, Zielinski, C C, Bartsch, R, Preusser, M
Published 2012

Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastases

by Bartsch, R, Berghoff, A, Pluschnig, U, Bago-Horvath, Z, Dubsky, P, Rottenfusser, A, DeVries, C, Rudas, M, Fitzal, F, Dieckmann, K, Mader, R M, Gnant, M, Zielinski, C C, Steger, G G
Published 2012

Brain metastases free survival differs between breast cancer subtypes

by Berghoff, A, Bago-Horvath, Z, De Vries, C, Dubsky, P, Pluschnig, U, Rudas, M, Rottenfusser, A, Knauer, M, Eiter, H, Fitzal, F, Dieckmann, K, Mader, R M, Gnant, M, Zielinski, C C, Steger, G G, Preusser, M, Bartsch, R
Published 2012

ESMO - Magnitude of Clinical Benefit Scale V.1.0 questions and answers

by Cherny, N I, Sullivan, R, Dafni, U, Kerst, J M, Sobrero, A, Zielinski, C, Piccart, M J, Bogaerts, J, Tabernero, J, Latino, N J, de Vries, E G E
Published 2016

Prognostic impact of breast cancer subtypes in elderly patients

by Bergen, E. S., Tichy, C., Berghoff, A. S., Rudas, M., Dubsky, P., Bago-Horvath, Z., Mader, R. M., Exner, R., Gnant, M., Zielinski, C. C., Steger, G. G., Preusser, M., Bartsch, R.
Published 2016

Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analyses

by Brodowicz, T, Lang, I, Kahan, Z, Greil, R, Beslija, S, Stemmer, S M, Kaufman, B, Petruzelka, L, Eniu, A, Anghel, R, Koynov, K, Vrbanec, D, Pienkowski, T, Melichar, B, Spanik, S, Ahlers, S, Messinger, D, Inbar, M J, Zielinski, C
Published 2014